Venus Remedies LimitedNSE: VENUSREM

Press Release Oct 26 2023

· Issued by Venus Remedies Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-26-2023-23

Venus Remedies Limited has informed the Exchange regarding a press release dated October 26, 2023, titled "Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in the United Kingdom".

View Attachment

6ix hasn’t read this filing yet.

Venus Remedies Limited on 6ix

Earlier from Venus Remedies

Later from Venus Remedies

All Venus Remedies news releases